Results 21 to 30 of about 3,405 (181)
PLoS ONE, 2022 BackgroundTuberculosis remains a major public health problem worldwide accounting for 1.4 million deaths annually. LL-37 is an effector molecule involved in immunity with both antimicrobial and immunomodulatory properties.
Ester Lilian Acen +6 more
doaj +1 more source
Screening for Latent Tuberculosis [PDF]
JAMA, 2016 This JAMA Patient Page describes latent and active tuberculosis and discusses the pros and cons of screening for latent tuberculosis.
openaire +2 more sources
Revista chilena de enfermedades respiratorias, 2012 La tuberculosis continúa siendo un problema enorme en salud pública. Se ha estimado que anualmente en todo el mundo 9 millones de personas contraen esta enfermedad y que 2 millones de muertes se deben a la tuberculosis. La exposición al M. tuberculosis causa la enfermedad en cerca del 10% de la población expuesta. En el 90% restante de los expuestos la
openaire +4 more sources
LATENT TUBERCULOSIS IN CHILDREN. [PDF]
JAMA: The Journal of the American Medical Association, 1906 The editorial inThe Journal, May 19, 1906, on "Latent Tuberculosis in Children" has induced me to submit notes (from memory) of a case of tuberculous meningitis appearing after recovery from measles. Personal and Family History. —John T., aged 3, illegitimate.
openaire +2 more sources
PLoS ONE, 2017 BackgroundThe majority of tuberculosis in migrants to Canada occurs due to reactivation of latent TB infection. Risk of tuberculosis in those with latent tuberculosis infection can be significantly reduced with treatment.
Jonathon R Campbell +5 more
doaj +1 more source
Latent Tuberculosis Infection as a Target for Tuberculosis Control [PDF]
Future Microbiology, 2015 WHO recently published guidelines for identifying and treating individuals with latent tuberculosis infection (LTBI) in high- and middle-income countries with a low incidence of active tuberculosis as part of the ‘End TB Strategy’ for the post-2015 era of tuberculosis control [1].
Leth, F. van +2 more
openaire +4 more sources
Treatment of Latent Tuberculosis Infection [PDF]
Current Treatment Options in Infectious Diseases, 2017 The treatment of latent tuberculosis infection (LTBI) is an essential component of tuberculosis (TB) elimination in regions that have a low incidence of TB. However, the decision to treat individuals with LTBI must consider the limitations of current diagnostic tests for LTBI, the risk of developing active TB disease, the potential adverse effects from
Tang, Patrick, Johnston, James
openaire +4 more sources
Determinants of latent tuberculosis infection among nurses at public health centers in Indonesia
Belitung Nursing Journal, 2021 Background: The incidence of latent tuberculosis among healthcare workers, especially nurses, at public health centers in Indonesia has been increased. Therefore, factors related to the tuberculosis incidence need to be further investigated. Objective:
Meira Erawati, Megah Andriany
doaj +1 more source
Heliyon, 2023 Objective: This cohort study aimed to determine the prevalence and risk factors of latent tuberculosis infection among healthcare workers during the COVID-19 pandemic.
Mojgan Sehat +4 more
doaj +1 more source
Revista Latino-Americana de Enfermagem, 2021 Objective: to identify the prevalence of latent tuberculosis in patients with chronic kidney disease on hemodialysis and associated factors. Method: a cross-sectional study conducted with 176 patients with chronic kidney disease on hemodialysis.
Viviane Ferreira +6 more
doaj +3 more sources